Scholars Central

Conference abstractPublished 23 Nov 2012

WHO/GMP based pharmaceutical industries and their concepts, challenges and opportunities in regulatory strategy

Authors: Nandita Dasgupta, Shivendu Ranjan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The demand for globally acceptable products heightens the imperative for harmonization of regulatory requirements to lend efficiency and cost effectiveness to the process of product development, manufacturing and expediency to global access. In addition, biopharmaceutical companies have continued to expand their frontiers to attain a global reach, with presence in many regions and countries, and therefore exposed to myriad, and sometimes diverse, regulatory requirements and operating standards. The challenges of globalization in a heterogeneous world with an evolving regulatory landscape and expectations of multiple stakeholders have increased the complexity, unpredictability and intensity of the biopharmaceutical product development and registration process. These challenges likewise reinforce the crucial role of the regulatory team and underscore the need for enhanced global regulatory function with regulatory professionals who are strong leaders, business partners and strategic contributors. Evolution in the regulatory profession has been largely driven by: Expanding scope and global reach of industry, Keen attention to global regulatory intelligence, Need for innovative and cutting edge technologies including e-submission, Complexity of disease area targets for development, Need for comprehensive and robust global regulatory strategies. The functional units of biopharmaceutical industries are: Product development HQ & regional; Chemistry, manufacturing and control (CMC), compliance, conformance; Policy and regulatory intelligence; Promotion and advertisement; Regulatory submission management; Product Labeling and its marketing.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Nandita Dasgupta”
  • BylineArticles whose byline prints “Shivendu Ranjan”